Construction of Clinical Evaluation Index System of National Generic Drugs Centralized Bidding Procurement
Qingqing Qiu , Wei Yan , Dongyan Xu , Shuyong Fu , Zheng Jia , Hua Xing
Asian Journal of Social Pharmacy ›› 2025, Vol. 20 ›› Issue (3) : 245 -255.
Construction of Clinical Evaluation Index System of National Generic Drugs Centralized Bidding Procurement
Objective To establish a scientific, reliable, objective, and effective clinical comprehensive evaluation system for drugs centralized bidding procurement by government, and to conduct reliability and validity test and empirical analysis of the evaluation index system through simulated measurement. Methods Literature research method was used to select comprehensive evaluation indicators for drugs centralized bidding procurement. Then, Dephi method was applied to screen the final evaluation indicators, and the weight of the indicators was determined using analytic hierarchy process. Results and Conclusion The final clinical efficacy evaluation index system for drugs centralized bidding procurement includes 5 primary indicators and 13 secondary indicators. The experts authority coefficient in this study is high, and their opinions relatively coincide. Through the empirical research, the reliability and structural validity of the indicator system is good. This indicator system enriches methods and tools for scientifically evaluating the clinical efficacy of drugs centralized bidding procurement.
procurement with quantity / clinical efficacy / evaluation index system / Delphi method / hierarchical analysis method / empirical analysis
| [1] |
National Health Commission. Notice of the General Office of the National Health Commission on Standardizing the Comprehensive Clinical Evaluation of Drugs[J]. Gazette of the National Health Commission of the People’s Republic of China, 2021 (7): 21-28. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
/
| 〈 |
|
〉 |